Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments

Isabelle Boutron; Lydia Guittet; Candice Estellat; David Moher; Asbjørn Hróbjartsson; Philippe Ravaud

doi:10.1371/journal.pmed.0040061

Related publications

Article2013

Assessing Risk of Bias in Randomised Clinical Trials Included in Cochrane Reviews: The why is Easy, the how is a Challenge

Asbjørn Hróbjartsson, Isabelle Boutron, Lucy Turner, Douglas G. Altman, David Moher

Article2008

Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments

Isabelle Boutron, David Moher, Douglas G. Altman, Kenneth F. Schulz, Philippe Ravaud

Article1994

A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group

Erik Andrew, Aslam H. Anis, Mildred K. Cho, Mike Clarke, David T. Felson, Peter C Gøtzsche, Richard E. Greene, Alejandro R. Jadad, Wayne B. Jonas, Terry P. Klassen, Paul Knipschild, Andreas Laupacis, Curtis L. Meinert, David Moher, Graham Nichol, Andy Oxman, Marie-France Penman, Stuart Pocock, Joan Reisch, David L. Sackett, Kenneth F. Schulz, Judy Snider, Peter Tugwell,

Article2013

Developing a Reporting Guideline for Social and Psychological Intervention Trials

Paul Montgomery, Evan Mayo‐Wilson, Sally Hopewell, Geraldine Macdonald, David Moher, Sean Grant

Article2018

Environmental risk factors and nonpharmacological and nonsurgical interventions for obesity: An umbrella review of meta‐analyses of cohort studies and randomized controlled trials

Marco Solmi, Cristiano A. Köhler, Brendon Stubbs, Ai Koyanagi, Beatrice Bortolato, Francesco Monaco, Davy Vancampfort, Myrela O. Machado, Michael Maes, Ioanna Tzoulaki, Joseph Firth, John P. A. Ioannidis, André F. Carvalho